| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.25 | 4e-08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |